miRNA
The company hopes to attract investors to fund its next steps after publishing early data from a training and validation study using public miRNA data.
The nonprofit behind the work aims to bring the test to market in the next 18 to 24 months and is in discussions with potential commercialization partners.
Mirxes, Universiti Kebangsaan Malaysia Partner on Colorectal Cancer Detection Test
The partners aim to develop a blood-based colorectal cancer test for the Malaysian market using Mirxes' proprietary microRNA technology.
Pharus Diagnostics Acquires Rights to Blood Cancer Biomarkers From City of Hope
The microRNA biomarkers were discovered in the lab of City of Hope researcher Ajay Goel, who has long been investigating their diagnostic potential in cancer.
XtalPi, CK Life Sciences Ink Deal to Develop MDx Risk Prediction Models for Cancer
The companies will combine artificial intelligence-based algorithms with anonymized clinical and biomarker data to develop the models.
Aug 5, 2021
Nov 4, 2020